Differences

This shows you the differences between two versions of the page.

--- timothy_springer [2023/02/04 08:39]
liam [History]
+++ timothy_springer [2023/02/04 08:47] (current)
liam
@@ Line 9: / Line 9: @@
 Springer founded [[pharmaceutical_companies:LeukoSite]] in 1993, which he took public in 1998 and sold to [[pharmaceutical_companies:Millennium Pharmaceuticals]] a year later in a deal worth $635 million.((Tognini, G. (2020, May 16). //Exclusive: Meet The Harvard Professor Who Became A Billionaire Thanks To Coronavirus.// Forbes. https://web.archive.org/web/20230203175707/https://www.forbes.com/sites/giacomotognini/2020/05/16/exclusive-harvard-professor-who-became-a-billionaire-thanks-to-moderna-talks-about-his-investing/?sh=5ac096b6b8d7))
-In February 2009, Springer invested in [[pharmaceutical_companies:Selecta Biosciences]].((Bratzler, R. (2009, February 25). //Selecta Biosciences, Inc. Closes $15.1M Series B Financing.// Flagship Pioneering. http://archive.today/2023.02.03-174945/https://www.flagshippioneering.com/press/selecta-biosciences-inc-closes-151m-series-b-financing)) Springer was a founding investor of [[pharmaceutical_companies:Moderna]] in 2010, when he put about $5 million into the company.
+In February 2009, Springer invested in [[pharmaceutical_companies:Selecta Biosciences]].((Bratzler, R. (2009, February 25). //Selecta Biosciences, Inc. Closes $15.1M Series B Financing.// Flagship Pioneering. http://archive.today/2023.02.03-174945/https://www.flagshippioneering.com/press/selecta-biosciences-inc-closes-151m-series-b-financing))
+Springer was a founding investor of [[pharmaceutical_companies:Moderna]] in 2010, when he put about $5 million into the company. In a May 2020 interview with [[Forbes]], Springer said that he and his co-investors "had the idea very early on that it could be used for pandemic readiness," adding "That’s why we invested in doing human trials with different influenza types, the types that are not normally seen in epidemics but could emerge and start a new pandemic. We were aware of this kind of scenario all along."
+He co-founded [[pharmaceutical_companies:Scholar Rock]] and [[pharmaceutical_companies:Morphic Therapeutic]].
+In May 2017, Springer donated $10 million to establish the [[Institute for Protein Innovation]] (IPI).((//About Us.// IPI. Retrieved February 4, 2023, from https://web.archive.org/web/20230204074432/https://proteininnovation.org/about-us/))
+==== COVID-19 ====
+Following the declaration of the [[COVID-19 pandemic]], Springer became a billionaire due to his founding investment in Moderna.
 ===== External links =====
   * [[https://en.wikipedia.org/wiki/Timothy_A._Springer|Wikipedia]]